BioSpace News Archive

Veracyte, Inc. (Nasdaq: VCYT) today announced that new data presented at the 2023 American Thyroid Association (ATA) Annual Meeting demonstrate the type of novel molecular insights for thyroid nodules and cancer that are enabled by analysis with the Afirma Genomic Sequencing Classifier (GSC).

Molecular Templates, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action, announced the appointment of Dr. Maurizio Voi to the role of Chief Medical Officer.

Wave Life Sciences Ltd., a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, held a virtual analyst and investor R&D Day, which highlighted the company’s growth strategy for building the leading RNA medicines company.

Nanoscope Therapeutics Inc. today announced that Dr. Sam Barone, Chief Medical Officer, will give a presentation on the clinical development of Nanoscope’s Multi-Characteristic Opsin (MCO) gene therapy platform at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit taking place from October 3-5 in Boston, Massachusetts.

Teva Pharmaceutical Industries Ltd. announced changes to its leadership team.

Better Therapeutics, Inc., a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, announced it has completed the enrollment of 1,000 participants across two studies as part of its ongoing clinical program to evaluate the long-term effectiveness of AspyreRxTM.

TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, announced that CEO Harlan Weisman, M.D. will attend and hold one-on-one investor meetings at the upcoming Jones Trading 2023 Healthcare Summit.

PTC Therapeutics, Inc. announced further strategic prioritization and associated workforce reduction.

Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2023.

Envoy Medical® Corporation (“Envoy”), a hearing health company, today announced that the proposed merger with Anzu Special Acquisition Corp I